Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Blood Cell Therapy|December 10, 2025
Successful Neutrophil Engraftment with Continued Ruxolitinib in Cord Blood TransplantationTomohiro Nagano, Takumi Kondo, Ryuichiro Hiyama, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 27, 2025
A fatal case of enterovirus A71-induced meningoencephalitis following allogenic hematopoietic stem cell transplantationYayoi Ueda, Hiroki Kobayashi, Hideaki Fujiwara, et al.
International Journal of Hematology|April 29, 2020
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapyKentaro Mizuhara, Nobuharu Fujii, Yusuke Meguri, et al.
Transplantation and Cellular Therapy|December 22, 2025
Spatial Transcriptomics Analysis of Macrophage-to-Myofibroblast Transition in Bronchiolitis Obliterans Following Hematopoietic Stem Cell TransplantationAkira Yamamoto, Nobuharu Fujii, Keisuke Seike, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2024
[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation]Fuminari Fujii, Toshiki Terao, Hisakazu Nishimori, et al.
Blood|December 18, 2024
Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host diseaseYui Kambara, Hideaki Fujiwara, Akira Yamamoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2023
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy]Tomoyasu Jo, Tomoko Henzan, Daisuke Tomizawa, et al.
British Journal of Haematology|April 25, 2023
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in JapanTomoyasu Jo, Satoshi Yoshihara, Yoshiki Okuyama, et al.
Pageof 11